MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$4,590K
Net Income
-$45,148K
Net Profit Margin
-983.62%
EPS
-$0.62
Unit: Thousand (K) dollars
Revenue Breakdown
Be One Medicines Ltd.-Drug Suppl...
Jazz-Royalty
Drug Supply For Ongoing Studies-...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development collaborations
4,590
2,408
2,515
27,614
Research and development
27,435
34,457
31,235
35,578
General and administrative
19,335
15,069
15,432
14,146
Impairment on ipr&d (note 6)
-
-
0
0
Total operating expenses
46,770
49,526
46,667
49,724
Loss from operations
-42,180
-47,118
-44,152
-22,110
Interest income
3,287
2,711
2,975
3,529
Interest expense related to sale of future royalties
6,595
2,066
-
-
Other income (expense), net
196
120
-302
315
Total other (expense) income, net
-3,112
765
2,673
3,844
(loss) income before income taxes
-45,292
-46,353
-41,479
-18,266
Income tax recovery (expense)
-273
-2,191
-270
1,336
Net (loss) income
-45,019
-44,162
-41,209
-19,602
Unrealized (gain) income on available for sale securities, net of tax of 0
-129
-486
-29
290
Total other comprehensive (gain) income
-129
-486
-29
290
Comprehensive (loss) income
-45,148
-44,648
-41,238
-19,312
Basic EPS
-0.62
-0.59
-0.547
-0.26
Diluted EPS
-0.62
-0.59
-0.563
-0.26
Basic Average Shares
72,993,313
74,668,790
75,343,622
75,767,778
Diluted Average Shares
72,993,313
74,694,762
73,273,534
75,775,214
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive (loss) income
-$45,148K
(-1994.59%↓ Y/Y)
Net (loss) income
-$45,019K
(-2042.99%↓ Y/Y)
Total other
comprehensive (gain) income
-$129K
(-295.45%↓ Y/Y)
Income tax recovery
(expense)
-$273K
(-46.77%↓ Y/Y)
(loss) income before
income taxes
-$45,292K
(-2225.39%↓ Y/Y)
Unrealized (gain) income on
available for sale...
-$129K
(-295.45%↓ Y/Y)
Be One Medicines
Ltd.-Drug Supply
$1,664K
(23671.43%↑ Y/Y)
Jazz-Royalty
$1,589K
(188.91%↑ Y/Y)
Drug Supply For
Ongoing Studies-Jazz
$791K
(-57.03%↓ Y/Y)
Jazz-Research Support
Payments And Other...
$291K
(-38.74%↓ Y/Y)
Be One Medicines
Ltd.-Royalty
$210K
(1005.26%↑ Y/Y)
Drug Supply-Jazz
$45K
Loss from operations
-$42,180K
(-6158.16%↓ Y/Y)
Total other (expense)
income, net
-$3,112K
(-210.94%↓ Y/Y)
Research and development
collaborations
$4,590K
(-90.58%↓ Y/Y)
Interest income
$3,287K
(-4.06%↓ Y/Y)
Other income
(expense), net
$196K
(131.56%↑ Y/Y)
Total operating
expenses
$46,770K
(-5.32%↓ Y/Y)
Interest expense related
to sale of future...
$6,595K
Research and development
$27,435K
(-20.36%↓ Y/Y)
General and
administrative
$19,335K
(29.32%↑ Y/Y)
Buy us a coffee
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)